Cumberland Pharmaceuticals Profit Margin

Cumberland Pharmaceuticals (CPIX) currently reports a profit margin of -17.24% as of March 2026. That compares with -7.98% in the prior-year period — down 116.2% year over year. That is below the Healthcare sector average of 15.52%. Use the charts on this page to explore Cumberland Pharmaceuticals's profit margin history and peer comparisons.

Cumberland Pharmaceuticals's profit margin decreased from -7.98% to -17.24% — a 116.2% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Cumberland Pharmaceuticals's profit margin of -17.24% is lower than the Healthcare sector average of 15.52%. That is roughly 211.1% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Cumberland Pharmaceuticals's current -17.24% should be judged against Healthcare norms (sector average: 15.52%) and against CPIX's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -17.24%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 15.52%. From there, open related valuation or income-statement pages for Cumberland Pharmaceuticals, and consider following CPIX for alerts when major investors trade the stock.